DoE to improve supercoiled p53-pDNA purification by O-phospho-l-tyrosine chromatography.

[1]  Xianting Ding,et al.  Orthogonal Array composite design to study and optimize antioxidant combinations in the prevention of UVB-induced HSF damage. , 2018, Journal of photochemistry and photobiology. B, Biology.

[2]  Â. Sousa,et al.  Chromatographic HPV‐16 E6/E7 plasmid vaccine purification employing L‐histidine and 1‐benzyl‐L‐histidine affinity ligands , 2017, Electrophoresis.

[3]  M. Andreeff,et al.  Pharmacological activation of wild-type p53 in the therapy of leukemia. , 2016, Experimental hematology.

[4]  S. H. van der Burg,et al.  A phase 1/2 study combining gemcitabine, Pegintron and p53 SLP vaccine in patients with platinum-resistant ovarian cancer , 2015, Oncotarget.

[5]  Â. Sousa,et al.  Optimization of supercoiled HPV-16 E6/E7 plasmid DNA purification with arginine monolith using design of experiments. , 2015, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[6]  X. Zou,et al.  Clinical utility of recombinant adenoviral human p53 gene therapy: current perspectives , 2014, OncoTargets and therapy.

[7]  Â. Sousa,et al.  Selective purification of supercoiled p53-encoding pDNA with L-methionine-agarose matrix. , 2014, Analytical biochemistry.

[8]  Â. Sousa,et al.  Histamine monolith versatility to purify supercoiled plasmid deoxyribonucleic acid from Escherichia coli lysate. , 2014, Journal of chromatography. A.

[9]  Â. Sousa,et al.  Purification of pre-miR-29 by a new O-phospho-l-tyrosine affinity chromatographic strategy optimized using design of experiments. , 2014, Journal of chromatography. A.

[10]  A. Valente,et al.  Plasmid DNA microgels for drug/gene co-delivery: A promising approach for cancer therapy , 2014 .

[11]  I Celardo,et al.  Senescence and aging: the critical roles of p53 , 2013, Oncogene.

[12]  Â. Sousa,et al.  Rapid quantification of supercoiled plasmid deoxyribonucleic acid using a monolithic ion exchanger. , 2013, Journal of chromatography. A.

[13]  Jo Wixon,et al.  Gene therapy clinical trials worldwide to 2012 – an update , 2013, The journal of gene medicine.

[14]  Angela Sousa,et al.  Advances in chromatographic supports for pharmaceutical-grade plasmid DNA purification. , 2012, Journal of separation science.

[15]  I. Correia,et al.  Nanoparticle mediated delivery of pure P53 supercoiled plasmid DNA for gene therapy. , 2011, Journal of Controlled Release.

[16]  Â. Sousa,et al.  Impact of lysine-affinity chromatography on supercoiled plasmid DNA purification. , 2011, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[17]  J. Wolff,et al.  Muscle damage after delivery of naked plasmid DNA into skeletal muscles is batch dependent. , 2011, Human gene therapy.

[18]  Angela Sousa,et al.  Differential interactions of plasmid DNA, RNA and genomic DNA with amino acid-based affinity matrices. , 2010, Journal of separation science.

[19]  Fani Sousa,et al.  Improvement of transfection efficiency by using supercoiled plasmid DNA purified with arginine affinity chromatography , 2009, The journal of gene medicine.

[20]  D. Prazeres,et al.  Affinity chromatography approaches to overcome the challenges of purifying plasmid DNA. , 2008, Trends in biotechnology.

[21]  I. Cree,et al.  Drug resistance in ovarian cancer — the role of p53 , 2008, Pathology & Oncology Research.

[22]  D. Prazeres,et al.  Dynamic binding capacity of plasmid DNA in histidine-agarose chromatography. , 2007, Biomedical chromatography : BMC.

[23]  Thomas Tuschl,et al.  Structural basis for 5′-end-specific recognition of guide RNA by the A. fulgidus Piwi protein , 2005, Nature.

[24]  A. Gelman.  Discussion of "Analysis of variance--why it is more important than ever" by A. Gelman , 2005, math/0508530.

[25]  T. Roberts,et al.  Induction of p53-Independent Apoptosis by Simian Virus 40 Small t Antigen , 2001, Journal of Virology.

[26]  Jhingook Kim,et al.  Intraperitoneal gene therapy with adenoviral-mediated p53 tumor suppressor gene for ovarian cancer model in nude mouse , 1999, Cancer Gene Therapy.

[27]  R. Lemmens,et al.  Plasmid DNA purification , 1998, Current Opinion in Neurobiology.

[28]  J. Roth,et al.  In vivo adenovirus-mediated p53 tumor suppressor gene therapy for colorectal cancer. , 1996, Anticancer research.

[29]  J. Roth,et al.  In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma. , 1995, Cancer research.

[30]  J. Roth,et al.  Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene. , 1994, Cancer research.

[31]  Jerome L. Myers,et al.  Research Design and Statistical Analysis , 1991 .